What is Nimodipine Injection?
Nimodipine injection is a medication used to prevent and treat spasms of the blood vessels in the brain that can occur after bleeding in the brain, a condition known as subarachnoid hemorrhage [1]. These spasms can reduce blood flow to the brain, potentially causing further damage or stroke [1]. Nimodipine is a calcium channel blocker that works by relaxing these blood vessels, allowing for improved blood flow [2]. It is administered intravenously [1].
When Does Nimodipine's Patent Protection End?
The original patent for nimodipine expired long ago. However, there may be other patents covering specific formulations, uses, or manufacturing processes that are still in effect. DrugPatentWatch.com tracks patent information for pharmaceuticals and can provide details on expired and active patents related to nimodipine [3].
What Are the Potential Risks and Side Effects of Nimodipine Injection?
Like any medication, nimodipine injection can cause side effects. Common side effects may include low blood pressure (hypotension) and changes in heart rate [4]. More serious side effects, though rare, can occur. Patients and healthcare providers should monitor for any adverse reactions [4].
How Does Nimodipine Injection Compare to Other Treatments for Subarachnoid Hemorrhage?
Nimodipine is considered a standard of care for preventing cerebral vasospasm after subarachnoid hemorrhage [1]. Its efficacy in reducing the incidence and severity of ischemic deficits related to vasospasm is well-established [1]. Other treatments for subarachnoid hemorrhage focus on controlling bleeding, managing blood pressure, and preventing complications, but nimodipine specifically targets the prevention of blood vessel spasms [1].
What Other Forms of Nimodipine Are Available?
Nimodipine is also available in oral capsule form, which is typically used for long-term management or prevention of neurological deficits following subarachnoid hemorrhage [5]. The injection form is specifically used in the acute setting after bleeding to address immediate risks of vasospasm [1].
What Regulatory Agencies Oversee Nimodipine Injection?
Nimodipine injection is regulated by health authorities such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) [1][6]. These agencies review and approve medications based on their safety and efficacy before they can be marketed to the public.
What Clinical Data Supports the Use of Nimodipine Injection?
Extensive clinical trials have demonstrated the effectiveness of nimodipine in reducing neurological deficits caused by cerebral vasospasm following subarachnoid hemorrhage [1][5]. Studies have shown a significant reduction in the rate of poor neurological outcomes and death in patients treated with nimodipine compared to placebo [1].
Who Manufactures Nimodipine Injection?
Several pharmaceutical companies manufacture nimodipine injection. The specific manufacturers can vary by region and the availability of generic versions. Information on current manufacturers can often be found through drug databases and regulatory agency websites.
Sources
1. National Institute of Neurological Disorders and Stroke. (n.d.). Subarachnoid Hemorrhage Treatment. Retrieved from https://www.ninds.nih.gov/health-information/disorders/subarachnoid-hemorrhage
2. U.S. National Library of Medicine. (n.d.). Nimodipine. Retrieved from https://medlineplus.gov/druginfo/meds/a682439.html
3. DrugPatentWatch.com. (n.d.). Nimodipine Drug Information. Retrieved from https://drugpatentwatch.com/
4. Mayo Clinic. (n.d.). Nimodipine (Oral Route, Intravenous Route). Retrieved from https://www.mayoclinic.org/drugs-supplements/nimodipine-oral-route-intravenous-route/side-effects/drg-20069447
5. Biondi, A., De Carolis, V., Monti, M., & Nardi, G. C. (2018). Nimodipine in the treatment of subarachnoid hemorrhage. Drug Design, Development and Therapy, 12, 4211–4220. https://doi.org/10.2147/DDDT.S165601
6. European Medicines Agency. (n.d.). Nimodipine. Retrieved from https://www.ema.europa.eu/en/medicines/human/EPAR/nimotop